In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece.
体外研究阿普拉霉素（EBL-1003）与粘菌素、美罗培南、米诺环素或舒巴坦联合治疗对来自希腊的XDR/PDR鲍曼不动杆菌分离株的活性
期刊:Journal of Antimicrobial Chemotherapy
影响因子:3.6
doi:10.1093/jac/dkae077
Galani I, Souli M, Katsala D, Karaiskos I, Giamarellou H, Antoniadou A
